Recently described timelines of the type I and type III IFN responses to SARS-CoV-2 infection offer insight into the mechanisms of proinflammatory cytokine storms during acute COVID-19 as well as its long-lasting effects as part of PACS. This evidence concerns the gene IFNA1 and COVID-19.